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Summary A number of reports associate human papillomavirus (HPV) with cervical cancer and cancer cell
lines denved from this tumour type. Considerably fewer reports have focused on the role of HPV in
carcinomas from other sites of female anogenital squamous epithelia. In this study we have tested for the
presence of HPV in eight low-passage vulvar carcinoma cell lines and one extensively passaged cell line, A431.
One cell line from a primary vaginal carcinoma was included. The presence of the HPV was evaluated by the
polymerase chain reaction (PCR), by Southern blot analysis and by two-dimensional gel electrophoresis.
General primer-mediated PCR was applied by using primers from the LI region, El region and HPV 16 E7
region. Southern blot hybridisation was performed under low-stringency conditions (T,., = - 35C) using a
whole genomic HPV 6/16/18 probe mixture and under high stringency conditions (T, = - 18C) with the
whole genomic probes of HPV 16 and 33. HPV 16 E6-E7 mRNA was assessed by ribonuclease protection
assay (RPA). HPV was found in only one vulvar carcinoma cell line, UM-SCV-6. The identified type, HPV 16,
was integrated in the cell genome and could be amplified with all primers used. Also E6-E7 transcripts were
found in these cells. Five original tumour biopsies were available from the HPV-negative cell lines for in situ
hybridisation. All these were HPV negative with both the HPV 6/16/18 screening probe mixture under low
stringency and the HPV 16 probe under high stringency. The results indicate that vulvar carcinoma cell lines
contain HPV less frequently than cervical carcinoma cell lines and suggest that a signifiant proportion of
vulvar carcinomas may evolve by an HPV-independent mechanism.
Keywords: vulvar neoplasms; human papillomavirus; cancer cell line; carcinogenesis
Numerous studies have shown that most cervical carcinomas
and cancer-derived cell lines contain human papillomavirus
(HPV) genomes, usually integrated in the host cell genome.
While HPV has been implicated in the aetiology of this
particular type of cancer, data on the role of HPV at other
genital sites are more fragmentary. There is some
epidemiological evidence that HPV infection is a risk factor
for vulvar carcinoma (Sherman et al., 1991). HPV DNA has
also been found in carcinoma samples of the vulva and
vagina (Buscema et al., 1988; Ikenberg et al., 1990; Anders-
sen et al., 1991; Bloss et al., 1991; Toki et al., 1991). HPV is
known to infect the squamous epithelium of the vagina and
vulva, and in doing so HPV may induce classical exophytic
condylomata, flat lesions or low-grade intraepithelial neo-
plasia. Follow-up studies have shown that such lesions may
progress to higher grades (Planner and Hobbs, 1988) in the
same manner as in the cervix (Syrjinen et al., 1988), although
this occurs infrequently. Moreover, koilocytic atypia has
been found within and in the vicinity of vulvar and vaginal
intraepithelial neoplasia (VIN, VAIN) and in a subset of
invasive neoplasia (Zaino et al., 1987), which indicates some
biological similarity with the pathogenesis of cervical neop-
lasia.
Many of the in vitro data evaluating the presence and
physical state of HPV in squamous carcinoma of the female
genital tract have been obtained using cancer cell lines
derived from the uterine cervix. There are no previous studies
on the presence of HPV DNA in cell lines derived from
extracervical genital squamous carcinomas. The major reason
for this has been the lack of suitable cell lines. We have
recently established and characterised cell lines from human
vulvar and vaginal carcinomas (Grenman et al., 1990; Wor-
sham et al., 1991). These cell lines, as well as the long-
established vulvar carcinoma cell line A431, have now been
studied for the presence of HPV.
Materials and methods
Cell lines
The establishment and characterisation of cell lines UM-
SCV-1, 2, 3, 4, 5 and 6 have been described previously
(Grenman et al., 1990; Worsham et at., 1991). Vulvar car-
cinoma cell line UM-SCV-7 and the vaginal carcinoma cell
line UM-SCVA-1 were more recently established in our
laboratory (S Grenman et al., unpublished). The cell lines are
summarised in Table I. Cultured cells were harvested with
trypsin-EDTA. Total DNA was extracted from the cells by
the method of Miller et al. (1988). Briefly, samples were lysed
in 1 ml of 10 mM Tris (pH 8.3), 400 mM sodium chloride, 1%
SDS, 2 mM EDTA and 0.3 mg ml1 proteinase K overnight
at 37TC. Proteins were precipitated by adding 300;LI of
saturated sodium chloride (approximately 6 M). After cent-
rifugation, DNA was precipitated from the supernatant with
ethanol. An HPV 16-positive cervical carcinoma cell line,
CaSki, was used as a control.
Southern blot hybridisation
Southern blotting followed the standard procedure. Briefly,
10Lg of restriction enzyme-digested or undigested cellular
DNA was loaded into individual lanes and run into 1.0%
agarose gels and transferred by Southern blotting to nylon
filters (Gene Screen, Dupont, Boston, MA, USA) for subse-
quent hybridisation. Restriction endonucleases PstI and
BanI, known to cut the HPV 16 genome, were used to digest
the genomic DNA. Hybridisation was performed with vector-
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Table I Cell lines and result of the HPV analysis
HPV in situ Detection
Age hybridisation of the Passage of of HPV in
Cell line Origin (years) original tumour cell line the cell line
UM-SCV-1A3 Vulva, primary tumour. SCC, 62 NA 14 -
grade II-III
UM-SCV-lBa Vulva, primary tumour, pleural - 14 -
effusion. SCC grade III
UM-SCV-2b Vulva, local recurrence. SCC, 86 NA 13 -
grade III
UM-SCV-3b Vulva, primary tumour. SCC, 66 - 19 -
grade II
UM-SCV_4b Vulva, pnrmary tumour. SCC, 41 - 13 -
grade?
UM-SCV-5b Vulva, local recurrence. SCC, 60 - 9 -
grade II
UM-SCV-6b Vulva, primary tumour. SCC, 43 NA 13 HPV 16
grade?
UM-SCV-7c Vulva, primary tumour. SCC. 77 NA 8
grade Il-III
A 431d Vulva. SCC, grade? 85 NA
UM-SCVA-Ic Vagina, local recurrence. SCC. 46 - 5
grade II
aGrenman et al. (1990). 'Worsham et al. (1991). cUnpublshed. dGiard et al. (1973). SCC, squamous cell carcinoma;
NA, original tumour not available.
free, whole genomic HPV probes labelled with [a-32PJdCTP
by nick translation (Life Technologies, Gaithersburg, MD,
USA). For screening, the samples were hybridised overnight
under low-stringency conditions (T,, = - 35'C), using a
whole genomic HPV 6/16/18 probe mixture. After screening,
the filters were rehybridised with HPV 16 and HPV 33
probes under high stringency (T, = - 18C). The filters were
exposed at -70'C for 1, 3 and 8 days. Before rehybridisa-
tion, the probe was removed from the filter by boiling with
0.1% SDS-1 mM EDTA for 2 m, followed by rapid cool-
ing at 20°C. Removal of the hybridised probes was confirmed
by exposing the filter for 24 h.
The absence of bacterial DNA in the cell lines was
confirmed by hybridisation of the filters with 16S RNA gene
probe. Bacterial ribosomal genes are highly conserved and
universally presented among bacterial species, particularly the
16S rRNA (Fox et al., 1980). the 16S rRNA gene probe was
prepared by PCR using Escherichia coli DNA as a template
to amplify a 1.3 kb product. The probe was labelled with 3P
using a multiprime method. The primers used were
T-ITGAGCTCAGATTGAACGCTG and ATTGGATCCA-
CGATTACTAGCG (Kauppinen et al., 1994). E. coli DNA
in decreasing concentrations (from 500 ng to 2 pg per lane),
digested with HindlII, was used as a positive control.
Integration analysis
The physical state of the HPV genome was studied with
two-dimensional gel electrophoresis. A 5 fig sample of
undigested genomic DNA was electrophoresed in a 0.4%
agarose gel at 20 V for 17 h. The sample was incubated at
56-C before electrophoresis. The resulting lane was cut from
the gel and recast in a 0.8% gel. This gel was electrophoresed
at 90g to the orginal direction, using 70 V for 4 h. DNA was
transferred to a filter and hybridised with 32P-labelled HPV
16 probe.
Polymerase chain reaction (PCR)
The presence of HPV DNA was studied using PCR with four
primer sets targeting the El, LI and HPV 16 E7 regions. The
primers are shown in Table II. The reaction took place on
300ng of genomic DNA in a 5001 l reaction volume. The
PCR solution contained 5 1il of 10 x PCR buffer (50 mM
potassium chloride, 10 mM Tris-HCI, pH 8.8, 1.5 mM
magnesium chloride, 0.1% Triton X-100), 0.75 units of
DynaZyme DNA polymerase (Finnzymes, Espoo, Finland),
200 gM of each deoxynucleotide triphosphate, 20 pmol of the
primers and sterile water. The template DNA was first
denatured for 4.5 min at 95°C and then exposed to 35 cycles
of denaturation at 95°C for 30 s, annealing at 55°C for 50 s
and extension at 72°C for 60 s in a thermal cycler (Cetus,
Norwalk, CT, USA). The amplification was completed by a
4 min extension step at 72C. We performed an additional
PCR with GP5 and GP6 primers in more relaxed conditions:
the template DNA was first denatured for 4.5 min at 95°C
and then exposed to 40 cycles of denaturation at 94°C for
60 s, annealing at 40C for 2 min and extension at 72°C for
90 s. HPV plasmid DNAs and DNA extracted from CaSki
cells were used as positive controls. No DNA was added to
the PCR solution of the negative controls. Both the
undigested and digested PCR products were electrophoresed
in 3% agarose gel (NuSieve, FMC BioProducts, Rockland,
ME, USA). Bands were visualised by ethidium bromide
staining. The PCR products with GP5-GP6 primers were
transferred to a filter and hybridised using a mixture of
whole genomic biotinylated HPV 6/16/18 probes under low-
stringency conditions (Tm = - 35C). The hybrids were
visualised with streptavidin-alkaline phosphatase complex
using nitroblue tetrazolium as chromogen and 5-bromo4-
chloro-3-indolyl phosphate as substrate (Syrjinen and
Syrjdnen, 1986). P-Globin was amplified to ensure that the
samples were appropriate for PCR. The sensitivity of the
PCR was tested with MY09-11 primers and CaSki cells. We
mixed 10000, 1000, 100, 50, 10, 5 and I CaSki cells with
300 ng of DNA extracted from normal human fibroblasts
and performed the PCR in the more stringent conditions as
described above. The PCR was still positive with one CaSki
cell (data not shown).
Ribonuclease protection assay (RPA)
Samples showing any bands in Southern blot hybridisation
were analysed for the presence of HPV 16 E6-E7 RNA
transcripts. The analysis included cell lines UM-SCV-lA,
-lB, -4, -5, -6, A431 and UM-SCVA-1. After DNAse
(RNAse-free) (Promega, Madison, WI, USA) treatment,
10fig of total cellular RNA was analysed with the RPAII kit
(Ambion, TX, USA) according to the manufacturer's instruc-
tions. The RNA samples were hybridised with the RNA
probe spanning from the upstream regulatory region to the
entire E6-E7 open reading frames (ORFs) of HPV 16
(nucleotide positions 7454-880). The 32P-labelled RNA pro-
bes were generated in the Bluescript transcription vector
using Riboprobe Gemini Systems (Promega), with T3 or T7
RNA polymerase according to the standard protocol sup-
plied by the manufacturer. The specific activity of the RNA
probe was 8 x 108 c.p.m. g-'. The sense orientation of the
135
IHWV in vu ad vaginal cacioma cdiIes
S Hienen et al
Tabk H Sequences of the oligonucleotide primers used for amplification of HPV and frGlobin
Target Primer Sequence Size (bp}
HPV LI MY 09g 5'-CGTCCMARRGGAWACTGATC-3' 448-454
MY1 1 5'-GCMCAGGGWCATAAYAATGG-3'
HPV LI GP5b 5'-TTTGTTACTGTGGTAGATAC-3' 140-150
GP6 5'-GAAAAATAAACTGTAAATCS-3'
HPV El plE1c 5'-TATGGCTATTCTGAAGTGGAA-3' 526-583
p2E1 5'-TTGATATACCTGTTCTAAACCA-3'
HPV 16 E7 E7AI 5'-GGATCCTACATTGCATGAATATATG-3' 272
E7A2 5'-CTGCAGATGGGGCACACAATTCCTA-3'
P-Globin frGlobin 1 5'-ACACAACTGTGTTCACTAGC-3' 110
P-Globin 2 5'-CAAC-TCATCCACGTTCACC-3'
M = A + C. R = A + T. W = A + T. Y = C + T. 'Manos et al. (1989). bvan den Brule et al. (1990). cContornii and Leoncini (1993).
probe served as a negative control. The hybridisation was
performed overnight with 32P-labelled probe (specific activity
2.5 x 105 c.p.m). After RNAse digestion and ethanol pre-
cipitation the samples were analysed in 5% polyacrylamide
gel in 8 M urea. The gel was exposed overnight at - 70°C.
In situ hkbridisation ofthe original tumour samples
Original tumour samples of cell lines UM-SCV-IB, -3, 4, -5
and UM-SCVA-1 were available for HPV in situ hybridisa-
tion. The hybridisation was performed with the HPV 6/16/18
mixture and HPV 16 probe under low and high stringency
respectively (Syrj&nen and Syrjanen, 1986).
Results
Southern blot analysis and two-dimensional gel electrophoresis
Only UM-SCV-6 hybridised clearly after 1 day's exposure to
the HPV 6/16/18 probe mixture under low stringency. Five
other vulvar cell lines (UM-SCV-1A, -1B, -4, -5 and A431)
and the vaInal cell line (UM-SCVA-1) showed some bands
after 8 days' exposure (Figures 1 and 2). The restriction
pattern of UM-SCV-6 was similar to that found with DNA
extracted from CaSki cells, indicating the presence of HPV
type 16. This was confirmed by rehybridisation with HPV 16
probe under high stringency (Figure 3). The other vulvar cell
lines and the vaginal cell line with positive bands under
low-stringency conditions also showed some faint bands after
hybridisation with HPV 16 probe under high stringency con-
ditions after long exposure (Figures 3 and 4). However, the
band sizes were less than expected for HPV and the restric-
tion pattern did not fit any of the known HPV types. Also,
the original tumour biopsies from these cell lines were HPV
DNA negative by in situ hybridisation (Table I). None of the
cell lines hybridised with the HPV 33 probe under high-
stringency conditions (data not shown). The copy number of
the HPV genome in UM-SCV-6 cells was some 200-300 as
judged from the comparison of hybridisation signals to the
CaSki cells (500-600 HPV 16 copies). HPV 16 DNA in
UM-SCV-6 cell line was integrated, since undigested samples
showed high molecular weight signals (Figure 3). The inte-
gration was confirmed by two-dimensional gel electro-
phoresis. Intense hybnrdisation signals were detected with
slowly migrating high molecular weight DNA, which are
compatible with integrated DNA sequences. No circular
sequences were detectable, indicating that UM-SCV-6 con-
tained no episomal sequences (Figure 5). The absence of
bacterial sequences in DNAs extracted from the cell lines was
confirmed by hybridising the filters with bacterial 16S rRNA
gene probe. E. coli DNA on the positive control filter yielded
detectable signals down to the concentration of 200 pg. All
cell lines were negative.
UM-SCV-5 UM-SCV-4 A431 UM-SCV-6
I B AB AB IA
A B C A B C A B C A B C
23.1 -
9.4 -
6.6 -
4.4 -
2.9 -
2.0 -
0.5 -
Fugwe 1 Autoradiogram of a Southern blot of cell lines UM-
SCV-4, -5, -6 and A431. Cellular DNA (lOtg) was electro-
phoretically separated, blotted and hybridised with an HPV 6/16/
18 probe mixture under low stringency. Exposure of the filter was
8 days. In each case, lane A contained PstI-digested DNA, lane B
BanI-digested DNA and lane C undigested DNA. Molecular
weight markers are HindlII fragments of phage lambda DNA.
Polymerase chain reaction
P-Globin was amplified in all cell lines. PCR with all three
primer sets from LI and El ORF amplified only DNA from
UM-SCV-6 cells. All other cell lines were negative. As the
Southern blot showed positive hybridisation signals with
HPV 16 under high stringency not only with UM-SCV-6, but
also with UM-SCV-1A, -lB, -4, -5, A431 and UM-SCVA-1,
these cell lines were reanalysed with PCR using HPV 16 E7
primers. Only UM-SCV-6 yielded positive amplification. In
order to detect other HPVs which might be less homologous
with the GP5 and GP6 primers, we performed an additional
PCR under more relaxed conditions. UM-SCV-6 and CaSki
were positive, but all others remained negative even after
hybridisation of the PCR products with a probe mixture of
HPV 6/16/18 under low stringency (data not shown).
HPV 16 E7-E6 mRNA analysis
HPV 16 E7-E6 transcripts were found only in UM-SCV-6
and CaSki cells as determined by ribonuclease protection
assay. All other cell lines were negative. Hybridisation with
the sense probe was negative with both CaSki and UM-SCV-
5 cells (Figure 6).WVi vraw aW - ani cdBHes
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Most cervical cancer biopsies and cell lines derived from
cervical cancer contain integrated HPV and have shown
transcripts from E6 and E7 ORFs of the persisting HPV
DNA (Schwartz et al., 1985; Yee et al., 1985). The role of
HPV in the carcinogenesis of other sites of female genital
squamous epithelium has been less clearly defined. In this
study we analysed the presence of HPV in one vaginal and
nine vulvar carcinoma cell lines. Only one vulvar cell line,
UM-SCV-6, contained HPV. This cell line contains integ-
rated HPV 16 and E6-E7 ORFs are transcribed. The faint
CaSki
A B C 1 2 3 4 5 6
CaSki
AB
A B C
137
1 2 3 4 5 6
23.1-
9.4-
6.6-
4.4-
2.9
2.0-
Fuwe4 Same filter as in Figure 3 now hybndised with HPV 16
probe under high stringency. Exposure: 8 days.
Fugwe 2 Cell lines UM-SCV-7 (lane 1), UM-SCVA-1 (lane 2),
UM-SCV-IA (lane 3), UM-SCV-IB (lane 4), UM-SCV-2 (lane 5)
and UM-SCV-3 (lane 6) hybridised under low stringency with a
mixture of probes HPV 6, 16 and 18. DNA was cut with PstIl.
Exposure: 8 days.
UM-SCV-5 UM-SCV-4 A431 UM-SCV-6
11
A B C A B C A B C A B C
23.1
9.4
6.6
4.4
2.9
2.0-
0.5-
Fugwe 3 Same filter as in Figure I hybridised with HPV 16
under high stringency. Exposure: 8 days.
Figwe 5 Two-dimensional gel electrophoresis of the UM-SCV-6
cell line. HPV 16 DNA is used as a hybridisation probe under
high stringency. The probe hybridises with linearised DNA which
migrates slowly with high molecular weight DNA, indicating that
this cell line contains only integrated HPV 16 DNA.
23.1 -
9.4-
6.6-
4.4 -
2.9-
2.0-
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FiguIre 6 Rionces prtcto asa to dec _P 16
Ei lE7 mRN Cak RNA seve as1 a po1tv conrowthth
prb alon (1 3 kb
hybndisa nceprtetion sinasnSothr bl to w etthHPV16prbm
srome cellanes migh UMSugges thriiedpreencofe antiunusualob
HPV. However, the sizes of the bands, the negative PCR
data with several pnmer sets even under permissive annealing
conditionss and the negative in situ hybridisation result of the
original tumours of UM-SCV-IB, -3, -4, -5 and UM-SCVA-l
argue against the presence of HPV. The possibility of
bacterial DNA was also excluded. It is possible that some of
the cellular sequences might cross-hybridise with HPV probes
and become visible in autoradiography, but only after long
exposure of the filter.
According to the data derived from clinical studies, there
are two different types of vulvar cancer, one associated with
HPV and the other not (Anderssen et al., 1991; Bloss et al.,
1991; Toki et al., 1991). The present study supports this view.
Chronic vulvar irritations including hyperplastic dystrophy
and lichen sclerosis et atrophicus, which are not associated
with sexually transmitted diseases, have been strongly linked
to invasive vulvar carcinoma (Pincus and Stadecker, 1987;
Zaino, 1987). Moreover, it has been shown that the associa-
tion of HPV and VIN decreases with age (Park et al., 1991),
whereas the incidence of vulvar carcinoma increases as a
function of age, unlike cervical cancer, which plateaus
between the fifth and eighth decades (Finnish Cancer Regis-
try database). Based on these observations and the results of
the present study, it appears that cervical and vulvar car-
cinomas are not aetiologically identical and that factors other
than HPV have a more important role in vulvar carcino-
genesis. We recently analysed these vulvar and vaginal cell
lines for the state of p53 gene and found that UM-SCV-6
and UM-SCV-1 contain wild-type p53, whereas all other cell
lines contain mutated p53 (Hietanen et al., in press). This
indicates that p53 mutations in vulvar carcinoma cell lines
are frequent and are detected in HPV-negative cell lines.
Furthermore, it is possible that p53 gene mutations are more
important in vulvar carcinogenesis than HPV infection.
In summary, the present results show that HPV is only
infrequently required in the establishment of vulvar SCC cell
lines and suggest that other factors may be more essential to
the abnormal growth of vulvar carcinoma ceUs.
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